Systemic inflammation after drug-eluting stent placement

Prospero B Gogo1, David J Schneider, Matthew W Watkins

  • 1Division of Cardiology, University of Vermont College of Medicine, 111 Colchester Avenue, Burlington, Vermont 05401, USA.

Insights

Drug-eluting stents (DES) reduce cardiac events compared to bare metal stents (BMS). This study found similar systemic inflammation markers (CRP, IL-6, IL1-Ra) after percutaneous coronary intervention (PCI) with either stent type, suggesting inflammation is not the key factor.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Inflammation Biology

Background:

  • Systemic inflammation post-coronary intervention is linked to increased cardiac event risk.
  • Drug-eluting stents (DES) are associated with fewer cardiac events than bare metal stents (BMS).
  • The potential role of reduced systemic inflammation in DES's improved outcomes requires investigation.

Purpose of the Study:

  • To investigate if the reduced restenosis observed with DES is due to a blunted systemic inflammatory response compared to BMS.
  • To compare the systemic inflammatory markers C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1 receptor antagonist (IL1-Ra) after PCI with DES versus BMS.

Main Methods:

  • A prospective registry of 75 patients undergoing percutaneous coronary intervention (PCI) was analyzed.
  • Peripheral venous blood samples were collected pre-PCI and 24 hours post-stenting.
  • Concentrations of CRP, IL-6, and IL1-Ra were measured using ELISA, with 11 patients excluded due to mixed stent use.

Main Results:

  • Patients receiving BMS (n=29) showed a higher incidence of marker-positive acute coronary syndromes and vein graft PCI compared to DES (n=34).
  • While baseline cytokine levels were lower in the DES group, both DES and BMS groups exhibited comparable, significant increases in CRP, IL-6, and IL1-Ra 24 hours post-PCI.
  • A robust 300% relative increase in CRP was observed in both DES and BMS patients after controlling for baseline levels.

Conclusions:

  • The systemic inflammatory response following PCI is similar for both DES and BMS.
  • The observed reduction in restenosis with DES is unlikely to be mediated by attenuation of systemic inflammatory markers (CRP, IL-1Ra, IL-6).
  • Further research may be needed to elucidate the mechanisms behind DES's improved clinical outcomes.
Abstract

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammation01:38

Inflammation

Overview
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...